Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases
Steady Weight Loss : Many patients lose a significant amount of weight over 612 months
Gastrointestinal symptoms during dose changes Nausea, constipation, and other GI symptoms are the most common side effects of GLP-1 therapy, and they tend to re-emerge whenever dosing changes occur
Studies indicate that GIP can effectively support weight loss, especially when combined with GLP-1 receptor agonists
Elevated levels of angiotensin-converting enzyme 2 (ACE2) expression are associated with producing various coronavirus peptidases
Order related labs such as: o Complete Blood Count (CBC) o Liver enzymes (AST, ALT, bilirubin) o Kidney function tests (creatinine, eGFR) o Methylmalonic acid (MMA) and homocysteine to check B12 activity